CRISPRQC INC.

Profile

Company Names

CRISPRQC INC.

Addresses

8949 KENAMAR DR, STE 101, SAN DIEGO, CA 92121

8949 KENAMAR DRIVE, STE 101, SAN DIEGO, CA 92121

8969 KENAMAR DR, STE 104, SAN DIEGO, CA 92121

Phone Numbers

(858) 444-0037

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$4,775,632.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2024-01-02 
$3,890,632.00 
$10,000,000.00 
$6,109,368.00 
Equity 
1
2022-03-08 
$885,000.00 
$4,000,000.00 
$3,115,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KIANA 
 
ARAN 
DIRECTOR
CRISPRQC INC.
GEORGE 
 
BONAROS 
DIRECTOR
CRISPRQC INC.   |  SEREN BIO CORP.
ROSS 
 
BUNDY 
EXECUTIVE OFFICER, DIRECTOR
NANOMEDICAL DIAGNOSTICS, INC.   |  CARDEA BIO, INC.   |  CRISPRQC INC.
PAUL 
 
GRINT 
DIRECTOR
NUMIRA BIOSCIENCES INC   |  SYNEDGEN, INC.   |  AMPLYX PHARMACEUTICALS, INC.   |  CARDEA BIO, INC.   |  CODAGENIX INC.   |  CRISPRQC INC.   |  INHIBIKASE THERAPEUTICS, INC.
ROSS 
 
HELGREN BUNDY 
EXECUTIVE OFFICER
CRISPRQC INC.
MICHAEL 
 
HELTZEN 
DIRECTOR
NANOMEDICAL DIAGNOSTICS, INC.   |  CARDEA BIO, INC.   |  CRISPRQC INC.   |  INVIZYNE TECHNOLOGIES INC
TOBY 
 
RICHARDSON 
DIRECTOR
CRISPRQC INC.
CHRIS 
 
YOO 
DIRECTOR
XCELLERANT FUND 3, LP   |  CRISPRQC INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-04-02
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-01-02 
2024-02-29
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-01-02 
2024-02-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-01-02 
2022-03-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-03-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#